Skip to main content

Table 4 OS and DFS for subgroup of patients with lower rectal cancer (tumor location< 7 cm from AV)

From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Group

Adjuvant chemotherapy Group (n = 63)

 

Adjuvant chemo-radiotherapy Group (n = 58)

P value

3-year

5-year

3-year

5-year

OS

90.48%

78.28%

 

91.38%

89.39%

0.316

DFS

76.19%

70.56%

 

91.32%

87.43%

0.015

  1. Abbreviations: adjuvant-chemo adjuvant chemotherapy, DFS disease-free survival, OS overall survival, AV anal verge